| Cancer cachexia: Diagnosis, assessment, and treatment M Sadeghi, M Keshavarz-Fathi, V Baracos, J Arends, M Mahmoudi, ... Critical reviews in oncology/hematology 127, 91-104, 2018 | 222 | 2018 |
| Effects of lead and cadmium on the immune system and cancer progression M Ebrahimi, N Khalili, S Razi, M Keshavarz-Fathi, N Khalili, N Rezaei Journal of Environmental Health Science and Engineering 18, 335-343, 2020 | 144 | 2020 |
| The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer SF Valilou, M Keshavarz-Fathi, N Silvestris, A Argentiero, N Rezaei Cytokine & growth factor reviews 39, 46-61, 2018 | 109 | 2018 |
| IL-17 and colorectal cancer: From carcinogenesis to treatment S Razi, BB Noveiry, M Keshavarz-Fathi, N Rezaei Cytokine 116, 7-12, 2019 | 108 | 2019 |
| Immunotherapy of cancers comes of age H Yousefi, J Yuan, M Keshavarz-Fathi, JF Murphy, N Rezaei Expert review of clinical immunology 13 (10), 1001-1015, 2017 | 99 | 2017 |
| Current and future perspectives of PD-1/PDL-1 blockade in cancer immunotherapy R Makuku, N Khalili, S Razi, M Keshavarz-Fathi, N Rezaei Journal of immunology research 2021, 1-15, 2021 | 96 | 2021 |
| A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications SS Sedighzadeh, AP Khoshbin, S Razi, M Keshavarz-Fathi, N Rezaei Translational lung cancer research 10 (4), 1889, 2021 | 89 | 2021 |
| Importance of TNF-alpha and its alterations in the development of cancers PM Sharif, P Jabbari, S Razi, M Keshavarz-Fathi, N Rezaei Cytokine 130, 155066, 2020 | 63 | 2020 |
| Survival benefits of dexmedetomidine used for sedating septic patients in intensive care setting: a systematic review MM Zamani, M Keshavarz-Fathi, MS Fakhri-Bafghi, A Hirbod-Mobarakeh, ... Journal of critical care 32, 93-100, 2016 | 49 | 2016 |
| Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site E Nasrollahzadeh, S Razi, M Keshavarz-Fathi, M Mazzone, N Rezaei Cancer Immunology, Immunotherapy 69 (9), 1673-1697, 2020 | 44 | 2020 |
| Roles of myeloid-derived suppressor cells in cancer metastasis: immunosuppression and beyond A Pastaki Khoshbin, M Eskian, M Keshavarz-Fathi, N Rezaei Archivum Immunologiae et Therapiae Experimentalis 67, 89-102, 2019 | 36 | 2019 |
| Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy? S Aghamiri, KF Mehrjardi, S Shabani, M Keshavarz-Fathi, S Kargar, ... Nanomedicine 14 (15), 2083-2100, 2019 | 35 | 2019 |
| Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy S Aghamiri, S Talaei, S Roshanzamiri, F Zandsalimi, E Fazeli, M Aliyu, ... Expert opinion on drug delivery 17 (6), 753-766, 2020 | 28 | 2020 |
| The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers M Gouravani, N Khalili, S Razi, M Keshavarz-Fathi, N Khalili, N Rezaei Expert Review of Clinical Immunology 16 (2), 175-187, 2020 | 22 | 2020 |
| Basic understanding and therapeutic approaches to target toll‐like receptors in cancerous microenvironment and metastasis M Khajeh Alizadeh Attar, MA Anwar, M Eskian, M Keshavarz‐Fathi, ... Medicinal Research Reviews 38 (5), 1469-1484, 2018 | 18 | 2018 |
| Cancer immunoprevention: current status and future directions M Keshavarz-Fathi, N Rezaei Archivum Immunologiae et Therapiae Experimentalis 69 (1), 3, 2021 | 16 | 2021 |
| Introduction on coronavirus disease (COVID-19) pandemic: the global challenge N Rezaei, S Ashkevarian, MK Fathi, S Hanaei, Z Kolahchi, ... Coronavirus Disease-COVID-19, 1-22, 2021 | 15 | 2021 |
| Chimeric antigen receptor T-cell therapy for melanoma A Razavi, M Keshavarz-Fathi, J Pawelek, N Rezaei Expert Review of Clinical Immunology 17 (3), 209-223, 2021 | 15 | 2021 |
| Chapter 3—Vaccines, Adjuvants, and Delivery Systems M Keshavarz-Fathi, N Rezaei Vaccines for Cancer Immunotherapy; Rezaei, N., Keshavarz-Fathi, M., Eds, 45-59, 2019 | 12 | 2019 |
| Natural killer cells and cancer therapy, what we know and where we are going F Ghaemdoust, M Keshavarz-Fathi, N Rezaei Immunotherapy 11 (14), 1231-1251, 2019 | 11 | 2019 |
Nima RezaeiTehran University of Medical Sciences; Universal Scientific Education and Research Network (USERN)Verified email at tums.ac.ir
